home / openregs / legislation

legislation: 110-hr-7200

Congressional bills and resolutions from Congress.gov, filtered to policy areas relevant to environmental, health, agriculture, and wildlife regulation.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

bill_id congress bill_type bill_number title policy_area introduced_date latest_action_date latest_action_text origin_chamber sponsor_name sponsor_state sponsor_party sponsor_bioguide_id cosponsor_count summary_text update_date url
110-hr-7200 110 hr 7200 Medical Information and Treatment Access Act Health 2008-09-28 2008-09-28 Referred to the Subcommittee on Health. House Rep. Cannon, Chris [R-UT-3] UT R C000116 0 Medical Information and Treatment Access Act - Requires the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to utilize an Internet site to consolidate and translate federal health care information for the public.Authorizes health care practitioners to provide unapproved treatments to their patients under specified conditions, including that: (1) the drug used must be an active ingredient in an approved drug or an unapproved drug that is approved for commercial distribution in a foreign country; (2) the practitioner receives informed consent from the patient; (3) the practitioner submits a registration to the Secretary before providing the treatment; and (4) the Secretary determines that there is no clear and convincing evidence that the treatment is unsafe. Deems the registration to be cleared if the Secretary fails to act within 90 days.Requires the Secretary to establish a program to maintain information regarding registrations under this Act.Directs the Secretary, acting through the Commissioner, to establish a program to gather information from practitioners regarding surgical procedures and make such information publicly available.Amends the Public Health Service Act to require the Director of the National Center for Complementary and Alternative Medicine to establish a program to gather information from health care practitioners regarding alternative medicine and make such information publicly available.Gives a drug or device company immunity from federal and state liability claims for: (1) the use of a relevant unapproved treatment by a practitioner under a cleared registration; and (2) the provision by the company of information upon the request of a practitioner if the company reasonably believes the information to be accurate. 2022-01-06T17:18:34Z  

Links from other tables

  • 6 rows from bill_id in legislation_actions
  • 11 rows from bill_id in legislation_subjects
  • 0 rows from bill_id in legislation_cosponsors
  • 0 rows from bill_id in cbo_cost_estimates
Powered by Datasette · Queries took 12.209ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API